Search alternatives:
larger decrease » marked decrease (Expand Search)
timer decrease » teer decrease (Expand Search), linear decrease (Expand Search), sizes decrease (Expand Search)
large decrease » marked decrease (Expand Search), large increases (Expand Search), large degree (Expand Search)
larger decrease » marked decrease (Expand Search)
timer decrease » teer decrease (Expand Search), linear decrease (Expand Search), sizes decrease (Expand Search)
large decrease » marked decrease (Expand Search), large increases (Expand Search), large degree (Expand Search)
-
2641
Summary of characteristics of studies reviewed.
Published 2024“…A random effects meta-analysis was performed comparing geometric mean titer (GMT) in PWH to PWoH. Twenty-eight studies out of 988 were eligible for inclusion in our study, and qualitatively synthesized. …”
-
2642
Cumulative meta-analysis.
Published 2024“…A random effects meta-analysis was performed comparing geometric mean titer (GMT) in PWH to PWoH. Twenty-eight studies out of 988 were eligible for inclusion in our study, and qualitatively synthesized. …”
-
2643
Summary of immunogenicity information.
Published 2024“…A random effects meta-analysis was performed comparing geometric mean titer (GMT) in PWH to PWoH. Twenty-eight studies out of 988 were eligible for inclusion in our study, and qualitatively synthesized. …”
-
2644
Table 1_Health care resource use and costs associated with adult pneumococcal disease in the United States from 2017 to 2019, stratified by age and health risk: a retrospective coh...
Published 2025“…</p>Results<p>The average health care resource use and direct costs associated with PD were significantly higher for IPD (mean [95% CI] overall cost $49,481 [$45,803–53,159] per episode; N = 949 affected individuals) than for NBPP with hospitalization ($27,330 [$23,807–30,852] per episode; N = 389) and NBPP without hospitalization ($1,090 [$927–1,252] per episode; N = 1,951). …”
-
2645
-
2646
-
2647
-
2648
Schematic diagram of monitoring points and units.
Published 2025“…Using the three-dimensional finite difference software FLAC<sup>3D</sup> (Fast Lagrangian Analysis of Continua), we conducted numerical simulations of both unreinforced and reinforced liquefiable sand foundations. A three-dimensional model was developed, incorporating dynamic analysis with the PL-Finn constitutive model to simulate post-liquefaction large deformations. …”
-
2649
The analysis procedure.
Published 2025“…Using the three-dimensional finite difference software FLAC<sup>3D</sup> (Fast Lagrangian Analysis of Continua), we conducted numerical simulations of both unreinforced and reinforced liquefiable sand foundations. A three-dimensional model was developed, incorporating dynamic analysis with the PL-Finn constitutive model to simulate post-liquefaction large deformations. …”
-
2650
Model monitoring points and units coordinates.
Published 2025“…Using the three-dimensional finite difference software FLAC<sup>3D</sup> (Fast Lagrangian Analysis of Continua), we conducted numerical simulations of both unreinforced and reinforced liquefiable sand foundations. A three-dimensional model was developed, incorporating dynamic analysis with the PL-Finn constitutive model to simulate post-liquefaction large deformations. …”
-
2651
Soil mechanical parameters.
Published 2025“…Using the three-dimensional finite difference software FLAC<sup>3D</sup> (Fast Lagrangian Analysis of Continua), we conducted numerical simulations of both unreinforced and reinforced liquefiable sand foundations. A three-dimensional model was developed, incorporating dynamic analysis with the PL-Finn constitutive model to simulate post-liquefaction large deformations. …”
-
2652
Parameters of the contact surface.
Published 2025“…Using the three-dimensional finite difference software FLAC<sup>3D</sup> (Fast Lagrangian Analysis of Continua), we conducted numerical simulations of both unreinforced and reinforced liquefiable sand foundations. A three-dimensional model was developed, incorporating dynamic analysis with the PL-Finn constitutive model to simulate post-liquefaction large deformations. …”
-
2653
The schematic diagram of free-field boundary.
Published 2025“…Using the three-dimensional finite difference software FLAC<sup>3D</sup> (Fast Lagrangian Analysis of Continua), we conducted numerical simulations of both unreinforced and reinforced liquefiable sand foundations. A three-dimensional model was developed, incorporating dynamic analysis with the PL-Finn constitutive model to simulate post-liquefaction large deformations. …”
-
2654
Residual deformation parameters of soil.
Published 2025“…Using the three-dimensional finite difference software FLAC<sup>3D</sup> (Fast Lagrangian Analysis of Continua), we conducted numerical simulations of both unreinforced and reinforced liquefiable sand foundations. A three-dimensional model was developed, incorporating dynamic analysis with the PL-Finn constitutive model to simulate post-liquefaction large deformations. …”
-
2655
Soil fluid and liquefaction parameters.
Published 2025“…Using the three-dimensional finite difference software FLAC<sup>3D</sup> (Fast Lagrangian Analysis of Continua), we conducted numerical simulations of both unreinforced and reinforced liquefiable sand foundations. A three-dimensional model was developed, incorporating dynamic analysis with the PL-Finn constitutive model to simulate post-liquefaction large deformations. …”
-
2656
PL-Finn model development procedure diagram.
Published 2025“…Using the three-dimensional finite difference software FLAC<sup>3D</sup> (Fast Lagrangian Analysis of Continua), we conducted numerical simulations of both unreinforced and reinforced liquefiable sand foundations. A three-dimensional model was developed, incorporating dynamic analysis with the PL-Finn constitutive model to simulate post-liquefaction large deformations. …”
-
2657
Risk of bias across 22 included studie.
Published 2024“…Consistently, participants receiving ketamine/esketamine had lower depression-related scores at 1- (standardized mean difference [SMD], −0.94; 95%CI, −1.26 to −0.62) and 4–6-week (SMD, −0.89; 95%CI, −1.25 to −0.53) follow-ups. …”
-
2658
An overview of the selection process for studies.
Published 2024“…Consistently, participants receiving ketamine/esketamine had lower depression-related scores at 1- (standardized mean difference [SMD], −0.94; 95%CI, −1.26 to −0.62) and 4–6-week (SMD, −0.89; 95%CI, −1.25 to −0.53) follow-ups. …”
-
2659
Characteristics of studies (<i>n</i> = 22).
Published 2024“…Consistently, participants receiving ketamine/esketamine had lower depression-related scores at 1- (standardized mean difference [SMD], −0.94; 95%CI, −1.26 to −0.62) and 4–6-week (SMD, −0.89; 95%CI, −1.25 to −0.53) follow-ups. …”
-
2660